Oligonucleotide analogues having modified intersubunit linkages and/or terminal groups
Abstract:
Oligonucleotide analogues comprising modified intersubunit linkages and/or modified 3′ and/or 5′-end groups are provided. The disclosed compounds are useful for the treatment of diseases where inhibition of protein expression or correction of aberrant mRNA splice products produces beneficial therapeutic effects.
Information query
Patent Agency Ranking
0/0